Topoisomerase IIα and IIβ expression in childhood acute lymphoblastic leukaemia: Relation to prognostic factors and clinical outcome

Journal of Clinical Pathology

Volumn 54, Issue 1, 2001, Pages 31-36

  Lodge, A J ^a   Hall, A G ^a   Reid, M M ^b   McIntosh, G G ^c   Steward, M ^c   Anderson, J J ^a   Horne, C H W ^c   Angus, B ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c Novocastra Laboratories Ltd   (United Kingdom)

Author keywords

Immunohistochemistry; Leukaemia; Prognosis; Topoisomerase

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ISOENZYME; MONOCLONAL ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CELL NUCLEUS; CHILD; CHILDHOOD LEUKEMIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DAUNORUBICIN; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; ENZYME INHIBITORS; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; ISOENZYMES; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0035158779     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.1.31     Document Type: Article

References (27)

1. Therapy for childhood acute lymphoblastic leukemia
2. Gender and treatment outcome in childhood lymphoblastic leukemia - Report from the MRC UKALL trials
3. CD10 in acute leukemias
4. Antisera to acute lymphoblastic leukemia cells
5. Proliferation-dependent and cell cycle-dependent differences in expression of the 170-kilodalton and 180-kilodalton forms of topoisomerase II in NIH-3T3 cells
6. Human DNA topoisomerase II: Evaluation of enzyme activity in normal and neoplastic tissues
7. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II
8. Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins
9. Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines
10. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells
11. Relationship of DNA topoisomerase II alpha and topoisomerase II beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines
12. Topoisomerase IIα gene expression in childhood acute lymphoblastic leukaemia
13. Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukaemia
14. Improved survival with early intensification: Combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI
15. Expression of topoisomerase IIIα in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody
16. Pixel-based image cytometry for quantification of nuclear antigen expression using Adobe Photoshop
17. Topoisomerase II alpha mRNA and tumour cell proliferation in non-Hodgkin's lymphoma
18. Expression of topoisomerase II alpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer
19. Immunohistochemical study of DNA topoisomerase II in human gastric disorders
20. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukemias
21. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and M-Amsa
22. Evidence for a critical role of DNA topoisomerase II alpha in drug sensitivity revealed by inducible antisense RNA in a human leukaemia cell line
23. Topoisomerase IIα expression in acute myeloid leukaemia and its relationship to clinical outcome
24. Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines
25. Topoisomerase II beta mRNA expression in acute myeloid leukaemia relationship to clinical outcome
26. Intensification of treatment and survival in all children with lymphoblastic leukemia - Results of UK Medical Research Council trial UKALL X
27. Method for quantifying expression of functionally active topoisomerase II in patients with leukemia